BSE Live
Dec 12, 16:01Prev. Close
825.80
Open Price
835.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 12, 15:53Prev. Close
833.40
Open Price
835.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
825.40 (270)
| Cash Flow of Venus Remedies (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 2.55 | -28.26 | -23.42 | -24.80 | 3.01 | |
| Net CashFlow From Operating Activities | 77.15 | 43.65 | 51.58 | 61.77 | 41.91 | |
| Net Cash Used In Investing Activities | -4.64 | -11.27 | -11.48 | -18.06 | 3.20 | |
| Net Cash Used From Financing Activities | -72.35 | -34.74 | -39.61 | -43.60 | -45.59 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 0.16 | -2.36 | 0.49 | 0.11 | -0.48 | |
| Cash And Cash Equivalents Begin of Year | 1.28 | 3.64 | 3.15 | 3.04 | 3.52 | |
| Cash And Cash Equivalents End Of Year | 1.44 | 1.28 | 3.64 | 3.15 | 3.04 |
17.11.2025
Venus Remedies Consolidated September 2025 Net Sales at Rs 192.75 crore, up 15.11% Y-o-Y
12.11.2025
Venus Remedies Standalone September 2025 Net Sales at Rs 192.65 crore, up 15.35% Y-o-Y
12.08.2025
Venus Remedies Consolidated June 2025 Net Sales at Rs 131.90 crore, up 21.44% Y-o-Y
05.08.2025
Venus Remedies Standalone June 2025 Net Sales at Rs 131.85 crore, up 24.55% Y-o-Y
17.11.2025
Venus Remedies Consolidated September 2025 Net Sales at Rs 192.75 crore, up 15.11% Y-o-Y
12.11.2025
Venus Remedies Standalone September 2025 Net Sales at Rs 192.65 crore, up 15.35% Y-o-Y
12.08.2025
Venus Remedies Consolidated June 2025 Net Sales at Rs 131.90 crore, up 21.44% Y-o-Y
05.08.2025
Venus Remedies Standalone June 2025 Net Sales at Rs 131.85 crore, up 24.55% Y-o-Y